Life Sciences Transgene and BioInvent Announce Clinical Trial Collaboration and Supply Agreement with MSD to… AIT News Desk Jun 28, 2022 Transgene , a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB, a biotech…
Healthcare Management KEYTRUDA (Pembrolizumab) Plus LENVIMA (Lenvatinib) Approved In Japan For Patients With Unresectable,… AIT News Desk Dec 27, 2021 First Approval in Japan for the KEYTRUDA Plus LENVIMA Combination Merck , known as MSD outside the United States and Canada, and Eisai announced that…
Computing Oracle Therapeutic Learning System Records Effectiveness of COVID-19 Drugs AIT News Desk Apr 2, 2020 For the last several weeks, Oracle has been actively engaged in the ongoing fight against COVID-19. Our primary goal has been to develop and deploy a…